Seguir
Mark Jaroszeski
Mark Jaroszeski
Dirección de correo verificada de usf.edu
Título
Citado por
Citado por
Año
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy
LM Mir, LF Glass, G Serša, J Teissie, C Domenge, D Miklavčič, ...
British journal of cancer 77 (12), 2336-2342, 1998
5871998
In vivo gene electroinjection and expression in rat liver
R Heller, M Jaroszeski, A Atkin, D Moradpour, R Gilbert, J Wands, ...
FEBS letters 389 (3), 225-228, 1996
5511996
Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo
G Niu, R Heller, R Catlett-Falcone, D Coppola, M Jaroszeski, W Dalton, ...
Cancer research 59 (20), 5059-5063, 1999
4701999
Theory and in vivo application of electroporative gene delivery
S Somiari, J Glasspool-Malone, JJ Drabick, RA Gilbert, R Heller, ...
Molecular Therapy 2 (3), 178-187, 2000
4052000
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy
R Heller, MJ Jaroszeski, LF Glass, JL Messina, DP Rapaport, RC DeConti, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 1996
3781996
Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin
R Heller, MJ Jaroszeski, DS Reintgen, CA Puleo, RC DeConti, RA Gilbert, ...
Cancer 83 (1), 148-157, 1998
3441998
Needle electrodes for mediated delivery of drugs and genes
GA Hofmann, RA Gilbert, Y Hayakawa, R Heller, MJ Jaroszeski
US Patent 5,702,359, 1997
3181997
Clinical applications of electrochemotherapy
R Heller, R Gilbert, MJ Jaroszeski
Advanced drug delivery reviews 35 (1), 119-129, 1999
2611999
Novel electrode designs for electrochemotherapy
RA Gilbert, MJ Jaroszeski, R Heller
Biochimica et Biophysica Acta (BBA)-General Subjects 1334 (1), 9-14, 1997
2201997
Toxicity of anticancer agents mediated by electroporation in vitro
MJ Jaroszeski, V Dang, C Pottinger, J Hickey, R Gilbert, R Heller
Anti-Cancer Drugs 11 (3), 201-208, 2000
2072000
Fundamentals of flow cytometry
MJ Jaroszeski, G Radcliff
Molecular biotechnology 11, 37-53, 1999
1491999
Bleomycin-mediated electrochemotherapy of metastatic melanoma
LF Glass, ML Pepine, NA Fenske, M Jaroszeski, DS Reintgen, R Heller
Archives of dermatology 132 (11), 1353-1357, 1996
1491996
In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity
L Heller, C Pottinger, MJ Jaroszeski, R Gilbert, R Heller
Melanoma research 10 (6), 577-583, 2000
1402000
Bleomycin-mediated electrochemotherapy of basal cell carcinoma
LF Glass, NA Fenske, M Jaroszeski, R Perrott, DT Harvey, DS Reintgen, ...
Journal of the American Academy of Dermatology 34 (1), 82-86, 1996
1351996
Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo
L Heller, MJ Jaroszeski, D Coppola, C Pottinger, R Gilbert, R Heller
Gene Therapy 7 (10), 826-829, 2000
1322000
Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma
LF Glass, M Jaroszeski, R Gilbert, DS Reintgen, R Heller
Journal of the American Academy of Dermatology 37 (4), 596-599, 1997
1321997
Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy
R Heller, M Jaroszeski, J Leo-Messina, R Perrot, N Van Voorhis, ...
Bioelectrochemistry and Bioenergetics 36 (1), 83-87, 1995
1311995
Electrochemotherapy, electrogenetherapy, and transdermal drug delivery: electrically mediated delivery of molecules to cells
MJ Jaroszeski, R Heller, R Gilbert
Humana Press, 2000
120*2000
In vivo gene delivery by electroporation
MJ Jaroszeski, R Gilbert, C Nicolau, R Heller
Advanced drug delivery reviews 35 (1), 131-137, 1999
1191999
Intradermal delivery of interleukin-12 plasmid DNA by in vivo electroporation
R Heller, J Schultz, ML Lucas, MJ Jaroszeski, LC Heller, RA Gilbert, ...
DNA and cell biology 20 (1), 21-26, 2001
1182001
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20